Episode 37 - Dr. Dave Miller and the Evolution of Drug Delivery Technologies

My Guest in this episode is Dr. Dave Miller. Dave is CSO of AustinPx and leads the pharmaceutics and analytical development teams and oversees the application of the KinetiSol™ Technology. Prior to his current position, Dr. Miller served as Vice President of Research and Development at DisperSol Technologies and Senior Principal Scientist at Hoffmann-La Roche. Dr. Miller is a co-inventor of the pharmaceutical applications of the KinetiSol technology. He has published over 40 research articles in peer-reviewed journals, authored 8 book chapters, and is co-editor of the First, Second, and Third Editions of the textbook, Formulating Poorly Water-Soluble Drugs. He is a co-inventor on numerous granted and pending patents worldwide. Dr. Miller holds a B.S. in Chemical Engineering and a Ph.D. in Pharmaceutics from the University of Texas at Austin. In this conversation, Dave shares his extensive journey in pharmaceutical research and development, highlighting the evolution of drug delivery technologies, particularly Kinetisol. He discusses the challenges of transitioning from R&D to commercialization, the importance of precision medicine, and the complexities of manufacturing in the pharmaceutical industry. Dave emphasizes the need for innovative approaches to drug formulation and the role of emotional intelligence in professional success. I enjoyed my chat with Dr. Dave Miller. Hope you do too. Here's Dr. Dave Miller.

You can listen to Episode 37 - Dr. Dave Miller and the Evolution of Drug Delivery Technologies online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 37 - Dr. Dave Miller and the Evolution of Drug Delivery Technologies is an episode from The Future of Pharma by Samir Gondalia, ISPE Boston.

This episode is 47:43 long.

This episode was published on Oct 16, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Future of Pharma when more episodes are available from the podcast feed.